论文部分内容阅读
目的观察莫西沙星治疗老年社区获得性肺炎的临床疗效。方法将88例老年社区获得性肺炎患者随机分为治疗组42例和对照组46例,治疗组给予莫西沙星静脉滴注3~5 d,口服莫西沙星序贯治疗3~6 d,平均疗程10 d。对照组给予头孢哌酮舒巴坦联合阿奇霉素静脉滴注,平均疗程14 d。结果治疗组疗效优于对照组。结论莫西沙星序贯治疗老年社区获得性肺炎安全有效,敏感性高。
Objective To observe the clinical efficacy of moxifloxacin in the treatment of elderly community-acquired pneumonia. Methods Eighty-eight elderly patients with community-acquired pneumonia were randomly divided into treatment group (n = 42) and control group (n = 46). The treatment group was given moxifloxacin intravenously for 3-5 days and the moxifloxacin sequential treatment for 3-6 days. The average Course of treatment 10 d. Control group was given cefoperazone sulbactam combined with azithromycin intravenous infusion, the average course of 14 d. Results The treatment group than the control group. Conclusion Moxifloxacin sequential treatment of elderly community-acquired pneumonia is safe and effective, high sensitivity.